Abuzahra, M. and Piso, B. (2010): Classification of disease severity for neuro- and trauma rehabilitation Part 3: Status quo in Austria. HTA-Projektbericht 23c.

Abuzahra, M. and Piso, B. (2009): Classification of disease severity for neuro- and trauma rehabilitation Part 2: International experiences with quality / performance assessments and reimbursement . HTA-Projektbericht 023b.

Emprechtinger, R. and Erdos, J. and Piso, B. (2016): Thrombectomy for ischaemic stroke: Patient characteristics, structural requirements and (differential) diagnostics. HTA-Projektbericht 87.

Erdos, J. and Mayer, J. (2015): Sphenopalatine Ganglion (SPG) stimulation of patients with therapy-resistant cluster headache. Decision Support Document 86.

Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Fuchs, E. (2019): Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis. HTA-Projektbericht 112.

Fuchs, S. and Grössmann, N. and Eckhardt, H. and Busse, R. and Wild, C. (2018): PET/PET-CT Evidence for need based planning in Germany and Austria. HTA-Projektbericht 77/ Update 2018.

Gassner, L. and Al Froukh, R.F. and Goetz, G. (2023): Transcranial magnetic resonance-guided high-intensity focused ultrasound treatment in patients with drug-resistant essential tremor. Decision Support Document 136.

Hofer, V. and Wild, C. (2022): Upper airway stimulation for moderate-to-severe sleep apnoea. Update 2022. Decision Support Document 100/ Update 2022.

Jeindl, R. and Wolf, S. (2024): Calcitonin gene-related peptide antagonists for the prevention of migraine - summary of the BAG /RACS HTA report 2023. Rapid Review Nr.: 011.

Kis, A. and Wild, C. and Bodamer, O. (2008): Enzyme Replacement Therapy for Lysosomal Storage Diseases. Decision Support Document 19.

Kisser, A. and Kirisits, A. (2015): Endovascular embolization of unruptured intracranial aneurysms with flow diverters. Decision Support Document 83.

Langer, T. (2006): [Role of neuroimaging for headache]. HTA-Newsletter 51: pp. 3-4.

Mathis, S. and Johansson, T. and Mad, P. and Mittermayr, T. (2011): Mechanical percutaneous transluminal cerebral clot retrieval devices in acute ischemic stroke: Systematic Review on efficacy and safety. Decision Support Document 46.

Naimer, Ch. and Piso, B. (2015): Outpatient neurological rehabilitation: goal attainment in stroke patients. Systematic review. Decision Support Document 92.

Pammer, C. and Abuzahra, M. and Wild, C. (2009): Classification of disease severity for neuro- and trauma rehabilitation Part 1: instruments for stroke and traumatic brain injury . HTA-Projektbericht 023a.

Reinsperger, I. and Geiger-Gritsch, S. (2019): Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019. Decision Support Document 100/ Update 2019.

Reinsperger, I. and Piso, B. (2012): Occupational Therapy Part III. Occupational therapy for patients after stroke. HTA- Projektbericht 59.

Salamon, Maria (2016): Screening, diagnostics and indication for occupational therapy in children and adolescents with Developmental Coordination Disorders. Decision Support Document 96.

Schiller-Frühwirth, I. and Kisser, A. (2016): Upper airway stimulation for moderate-to-severe sleep apnea. Decision Support Document 100.

Stanak, M. and Wolf, S. and Jagoš, H. (2018): External stimulation of the trigeminal nerve for the prevention and acute treatment of episodic and chronic migraine. Decision Support Document 114.

Warmuth, M. and Stumpner, T. (2012): Therapeutic hypothermia (TH). Decision Support Document 63.

Wild, C. and Erdos, J. and Jeindl, R. (2024): Biomarkers in Parkinson's Disease. Rapid Review Nr.: 010.

Wild, C. (2006): [Carotid stenting for carotid artery stenosis]. HTA-Newsletter 46: p. 4.

Wild, C. (2006): [Interferon-beta for multiple sklerosis]. HTA-Newsletter 45: pp. 2-3.

Wild, C. (2005): [Cerebral microdialysis: Neuromonitoring]. HTA-Newsletter 42: p. 4.

Wild, C. (2005): [Stroke rehabilitation] . HTA-Newsletter 41: p. 2.

Wild, C. (2005): [Neuromodulation in patients with Parkinson´s disease or chronic pain]. HTA-Newsletter 37: p. 2.

Wild, C. (2004): [Stereotactic radiosurgery]. HTA-Newsletter 25: p. 4.

Wild, C. (2004): [Electrostimulation after stroke]. HTA-Newsletter 25: pp. 3-4.

Wild, C. (2003): [Treatment of chronic pain: Multidisciplinary programmes]. HTA-Newsletter 18: pp. 3-4.

Wild, C. (2002): [Pallidotomy in Parkinson's disease]. HTA-Newsletter 07: p. 4.

Wild, C. (2001): [Botulinim toxin and other spasmolytics for treatment of spasticity]. HTA-Newsletter 03: p. 3.

Wild, C. (2001): [Chronic fatigue syndrome]. HTA-Newsletter 01: p. 2.

Wild, C. (2006): [Neuromodulation for Parkinson´s disease and chronic pain]. ÖKZ: Österreichische Krankenhauszeitung 47 (02): p. 16.

Wild, C. (2000): [Erythropoietin in patients with fatigue syndrome]. forum dr. Med. (13): pp. 4-5.

Wolf, S. and Erdos, J (2021): Epidemiology of long COVID: a preliminary report. German short version of the original KCE report. HTA-Projektbericht 135a.